Who owns Amicus Therapeutics?
- Ticker: FOLD
- CUSIP Number: 03152W109
Tip: Access positions for across all investors
Analyze quarterly positions in Amicus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Amicus Therapeutics stock
Who bought or sold Amicus Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| State Street Corporation | 13M | $186M | -13% | Mar 2026 |
|
| Morgan Stanley | 7.0M | $101M | 28% | Mar 2026 |
|
| Citigroup | 4.4M | $64M | 100% | Mar 2026 |
|
| CIBRA Capital | 1.7M | $24M | 701% | Mar 2026 |
|
| Henderson Group | 1.1M | $16M | 100% | Mar 2026 |
|
| T. Rowe Price Associates | 339k | $4.9M | 20% | Mar 2026 |
|
| CWM | 51k | $735k | 0% | Mar 2026 |
|
| Bank Of Montreal | 25k | $361k | 100% | Mar 2026 |
|
| Bck Capital Management | 20k | $289k | 100% | Mar 2026 |
|
| IFP Advisors | 796.00 | $12k | -2% | Jun 2026 |
|
| Huntington National Bank | 1.00 | $14.000000 | 0% | Jun 2026 |
|